Eriko Nakata

A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain

Yuta Matsumura, Tomohiro Yamashita, Atsushi Sasaki et al. · Scientific Reports · 2016 · 127 citations · Full text

Transforming Growth Factor β Triggers Two Independent-Senescence Programs in Cancer Cells

Yoshinori Katakura, Eriko Nakata, Takumi Miura et al. · Biochemical and Biophysical Research Communications · 1999 · 114 citations

Tumor Biology, Cancer Cell Biology, Cellular Senescence +10

Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3<i>R</i>)-3-piperidinyl]-1<i>H</i>-benzimidazole: Design, Synthesis, and Structure−Activity Relationship of Oral Receptor Occupancy in the Brain for Orally Potent Antianxiety Drug

Shigeo Hayashi, Akiko Hirao, Aki Imai et al. · Journal of Medicinal Chemistry · 2009 · 46 citations · Full text

Pain Disorders, Central Nervous Systems, Molecular Pain +20

Combined Memory and Executive Function Tests Can Screen Mild Cognitive Impairment and Converters to Dementia in a Community: The Osaki-Tajiri Project

Eriko Nakata, Mari Kasai, Masashi Kasuya et al. · Neuroepidemiology · 2009 · 46 citations

Bidirectional Regulation of Telomerase Activity in a Subline Derived from Human Lung Adenocarcinoma

Yoshinori Katakura, Katsuhiko Yamamoto, Osamu Miyake et al. · Biochemical and Biophysical Research Communications · 1997 · 23 citations

Tumor Biology, Oncogenic Agent, Telomerase Activity +10